Caffeinol

N/A

Report date: 2026/01/21 20:00:47

Base Information

Drug NameCaffeinol
Drug Alias Namecaffeine/ethanol
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists
TargetsAdenosine A1 receptorAdenosine A2a receptor
Therapy Area/IndicationsIschemic StrokeDisruptive, Impulse Control, and Conduct DisordersAlcoholism +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Caffeine
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCardium Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesThe Ohio State UniversityJohns Hopkins University
Inactive CompaniesThe University Of Texas Health Science Center At Houston
Active IndicationsDisruptive, Impulse Control, and Conduct DisordersAlcoholic IntoxicationCarcinoma, Non-Small-Cell Lung
Inactive IndicationsIschemic StrokeAlcoholism

Other Information

ATC CodeN/A
Related LinksN/A